US Patent 12065502 Bispecific antibody formulation
Patent 12065502 was granted and assigned to Hoffmann-La Roche Limited on August, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 21 Aug, 2024
Golden AI
Edits made to:
Infobox (+26 properties)
Article (+208 characters)
US Patent 12065502 Bispecific antibody formulation
Article
Patent abstract
This invention relates to a pharmaceutical formulation of a bispecific antibody which binds to carcinoembryonic antigen (CEA) and CD3, a process for the preparation and uses of the formulation.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Anja Sarah Paulus0
Jonas Fast0
Date of Patent
August 20, 2024
0Patent Application Number
167506460
Date Filed
January 23, 2020
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 12065502 Bispecific antibody formulation
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
